Changes in the offering

Based on Swedish Securities Councils statement earlier today, after further discussions with interested parties, Brighter has now chosen to comply with the formal recommendation and therefore organize public trading in subscription rights in connection with the present rights issue. The significance of this is that the company will now adjust the issue offer that was published on November 18 and organize trading in subscription rights.

“The important thing for Brighter is still that as much as possible of the proceeds goes to the company and thus benefits the shareholders. The change in the offering will not add any guarantors or similar players,” says Henrik Norström, CEO of Brighter AB.

Trading in subscription rights will continue from December 18, 2019 through January 8, 2020. The subscription period in the offer will be extended and will thus run from December 13, 2019 through January 10, 2020.

The prospectus that the company has prepared for the issue needs to be updated with the new information but is expected to be approved and published during the evening.

For further information, please contact:

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
Email: ann.zetterberg@brighter.se

Henrik Norström, CEO  
Phone: +46 733 40 30 45     
Email: henrik.norstrom@brighter.se

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 18:11 CET on December 12, 2019.

About Us

Brighter is a Swedish health-tech company with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links